HIV-1 protease: Characterization of a catalytically competent enzyme-substrate intermediate

被引:11
作者
Porter, DJT [1 ]
Hanlon, MH [1 ]
Furfine, ES [1 ]
机构
[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/bi0116543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The steady-state and pre-steady-state kinetic parameters for the interaction of E with the fluorogenic substrate 2-aminobenzoyl-Thr-Ile-Nle-Phe(p-NO2)-Gln-Arg-NH2 were determined in 1.25 M NaCl, 0.1 M MES-TRIS at pH 6.0 at 25 degreesC. At low concentrations of enzyme, the values of the Km and k(cat) calculated from steady-state data were 2.1 muM and 7.4 s(-1), respectively. At high concentrations of enzyme, the time-courses of fluorescence enhancement associated with catalysis were very dependent on the excitation wavelength used to monitor the reaction. Because the absorbance spectrum of the substrate overlapped the fluorescence emission spectrum of the enzyme, these abnormalities were attributed to fluorescence energy transfer between the enzyme and the substrate in an enzyme-substrate intermediate. The kinetic data collected with lambda(ex) = 280 nm and lambda(em) > 435 nm were analyzed according to the following mechanism in which EX was the species with enhanced fluorescence relative to substrate or products: E + S reversible arrow(K) ES (reversible arrow)(k-2) (k2) EX -->(k3) E + P The values of the kinetic parameters with (H2O)-H-1 as the solvent were K = 13 muM, k(2) = 150 s(-1), k(-2) = 25 s(-1), and k(3) = 11 s(-1). The values of the kinetic parameters with (H2O)-H-2 as the solvent were K = 13 muM, k(2) = 210 s(-1), k(-2) = 12 s(-1), and k(3) = 4.4 s(-1). These values yielded solvent isotope effects of 2 on k(cat) and 0.9 on k(cat)/K-m. From analysis of the complete time-course of the fluorescence change (lambda(ex) = 280 nm and lambda(em) > 435 nm) during the course of substrate hydrolysis, the intermediate EX was determined to be 6.3-fold more fluorescent than the product, which, in turn, was 4.5-fold more fluorescent than ES or S. Rapid quench experiments with 2 N HCl as the quenching reagent confirmed that EX was a complex between enzyme and substrate. Consequently, the small burst in fluorescence observed when monitoring with lambda(ex) = 340 nm (0.3 product equiv per enzyme equivalent) was attributed to the fluorescence change upon transfer of substrate from an aqueous environment to a nonaqueous environment in the enzyme. These results were consistent with carbon-nitrogen bond cleavage being the major contributor to k(cat) .
引用
收藏
页码:1302 / 1307
页数:6
相关论文
共 24 条
[1]   INHIBITION OF HIV PROTEASE ACTIVITY BY HETERODIMER FORMATION [J].
BABE, LM ;
PICHUANTES, S ;
CRAIK, CS .
BIOCHEMISTRY, 1991, 30 (01) :106-111
[2]  
CHENG YSE, 1990, P NATL ACAD SCI USA, V87, P9960
[3]   SOLVENT ISOTOPE EFFECTS ON THE ONSET OF INHIBITION OF PORCINE PEPSIN BY PEPSTATIN [J].
CHO, YK ;
REBHOLZ, KL ;
NORTHROP, DB .
BIOCHEMISTRY, 1994, 33 (32) :9637-9642
[4]  
FERSHT A, 1985, ENZYME STRUCTURE MEC, P135
[5]   USE OF GLASS ELECTRODES TO MEASURE ACIDITIES IN DEUTERIUM OXIDE [J].
GLASOE, PK ;
LONG, FA .
JOURNAL OF PHYSICAL CHEMISTRY, 1960, 64 (01) :188-190
[6]   USE OF PROTEIN UNFOLDING STUDIES TO DETERMINE THE CONFORMATIONAL AND DIMERIC STABILITIES OF HIV-1 AND SIV PROTEASES [J].
GRANT, SK ;
DECKMAN, IC ;
CULP, JS ;
MINNICH, MD ;
BROOKS, IS ;
HENSLEY, P ;
DEBOUCK, C ;
MEEK, TD .
BIOCHEMISTRY, 1992, 31 (39) :9491-9501
[7]   HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE .2. USE OF PH RATE STUDIES AND SOLVENT KINETIC ISOTOPE EFFECTS TO ELUCIDATE DETAILS OF CHEMICAL MECHANISM [J].
HYLAND, LJ ;
TOMASZEK, TA ;
MEEK, TD .
BIOCHEMISTRY, 1991, 30 (34) :8454-8463
[8]   HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE .1. INITIAL VELOCITY STUDIES AND KINETIC CHARACTERIZATION OF REACTION INTERMEDIATES BY O-18 ISOTOPE EXCHANGE [J].
HYLAND, LJ ;
TOMASZEK, TA ;
ROBERTS, GD ;
CARR, SA ;
MAGAARD, VW ;
BRYAN, HL ;
FAKHOURY, SA ;
MOORE, ML ;
MINNICH, MD ;
CULP, JS ;
DESJARLAIS, RL ;
MEEK, TD .
BIOCHEMISTRY, 1991, 30 (34) :8441-8453
[9]   ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].
KOHL, NE ;
EMINI, EA ;
SCHLEIF, WA ;
DAVIS, LJ ;
HEIMBACH, JC ;
DIXON, RAF ;
SCOLNICK, EM ;
SIGAL, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690
[10]   Program DYNAFIT for the analysis of enzyme kinetic data: Application to HIV proteinase [J].
Kuzmic, P .
ANALYTICAL BIOCHEMISTRY, 1996, 237 (02) :260-273